Among the latest news in the area of alopecia (hair loss) is a process unique new regeneration of hair growth through the formation of new hair follicles. Known as neurogenesis follicle, is a kind of cloning that attempts to create "hair seeds" which can then help the growth of new follicles.
"In essence, the method a sample drawn out of your hair, you are seeded in the laboratory where microdisecati follicles are extracted and isolated cells that the body uses to hair synthesis," says Reed.
These cells, he says, are then purified and cloned to produce more cells, which are then back to the micro-balding area where they cause cells to this level to produce more hair follicles.
While the system is still developing, Reed says it will take years until you have a clinical purpose. In one study, a similar cloning proved that it works in rodents. But until now, Reed said that these specific results have not been published.
Avodart
Is more realistic to treat drug Avodart (dutasteride), a cousin of the already known Finasteride (Prophecies and Proscar) and initially designed to treat diseases prostates. The big difference, though, is that while finasteride helps to block an enzyme involved in the conversion of testosterone to dihydrotestosterone, Avodart second seems to block enzymes and it can be a real advantage for women.
"Propecia reduces DHT levels in the body by 50% -55%, Proscar reduces it by 65% -70%, but it Avodart reduces up to 94% - so the advantage is significant," said Reed.
Although still considered experimental for female pattern hair loss, is currently used in small laboratory studies and only in selected women who can not get pregnant.
Reed is one of the doctors who tested the drug on women, says that he was tried in those patients for which Proscar failed one or more years after treatment. He is optimistic regarding the results achieved so far.
"It might be best for women blocking the enzyme that we have," said Reed.
Hair transplants
Finally, while hair transplants for men have long been considered the treatment of choice, they have rarely been considered appropriate for women - mostly aesthetic reasons. However, reporting in the November 2003 Journal of the American Academy of Dermatology, doctors at Mount Sinai Medical School in New York says that advances in transplantation technology - including a healing less - coupled with more realistic expectations, make hair transplantation a viable option for women.
Rather than graft harvest appear one by one and transplanting them into another area of the scalp, current techniques for harvesting a graft strip form, then splits into several smaller parts that are surgically implanted exactly where needed hair - even between hairs that grow naturally again.
However, experts recommend that women consider hair transplantation only after a dermatological consultation, even after diagnosis and a cure after drug treatment.
